After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a ...

Months after Massachusetts voters rejected a ballot question that would permit adults to use and grow certain psychedelic drugs, some state lawmakers have begun proposing bills to legalize psilocybin.

Pay-Per-Click (PPC) Management: Targeted PPC campaigns across platforms like Google and social media, focusing on treatments such as ketamine infusion, Spravato (Esketamine), TMS therapy ...

Spravato is the first ketamine-based medicine approved to treat depression, and also the first of a new class of glutamate NMDA receptor-targeting drugs that have ended a decades-long drought at ...

Spravato has been approved since 2019 for TRD ... an intranasal formulation of racemic ketamine.

The largest life sciences association in the state recognized those driving discovery during its 32nd annual dinner meeting ...

The Food and Drug Administration (FDA) has not approved ketamine as a treatment for any psychiatric disorder. The only FDA-approved option is Spravato, a nasal spray made from a derivative of ketamine ...